IL118325A0 - Integrin receptor antagonists and pharmaceutical compositions containing them - Google Patents
Integrin receptor antagonists and pharmaceutical compositions containing themInfo
- Publication number
- IL118325A0 IL118325A0 IL11832596A IL11832596A IL118325A0 IL 118325 A0 IL118325 A0 IL 118325A0 IL 11832596 A IL11832596 A IL 11832596A IL 11832596 A IL11832596 A IL 11832596A IL 118325 A0 IL118325 A0 IL 118325A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- receptor antagonists
- integrin receptor
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45064695A | 1995-05-25 | 1995-05-25 | |
US45576895A | 1995-05-31 | 1995-05-31 | |
US08/647,132 US5710159A (en) | 1996-05-09 | 1996-05-09 | Integrin receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL118325A0 true IL118325A0 (en) | 1996-10-31 |
Family
ID=27412454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11832596A IL118325A0 (en) | 1995-05-25 | 1996-05-20 | Integrin receptor antagonists and pharmaceutical compositions containing them |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0828737A1 (fr) |
JP (1) | JPH11506436A (fr) |
AU (1) | AU5876296A (fr) |
CA (1) | CA2221980A1 (fr) |
IL (1) | IL118325A0 (fr) |
MX (1) | MX9708840A (fr) |
WO (1) | WO1996037492A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5760028A (en) * | 1995-12-22 | 1998-06-02 | The Dupont Merck Pharmaceutical Company | Integrin receptor antagonists |
EP0888344A1 (fr) * | 1996-03-15 | 1999-01-07 | The Du Pont Merck Pharmaceutical Company | Inhibiteurs de l'integrine spirocycle |
ZA972195B (en) * | 1996-03-15 | 1998-09-14 | Du Pont Merck Pharma | Spirocycle integrin inhibitors |
DK0894084T3 (da) * | 1996-03-29 | 2002-10-14 | Searle & Co | Kanelsyrederivater og deres anvendelse som integrinantagonister |
US6185453B1 (en) | 1996-06-19 | 2001-02-06 | Dupont Pharmaceuticals Company | Iontophoretic delivery of integrin inhibitors |
US6214834B1 (en) | 1997-03-28 | 2001-04-10 | Dupont Pharmaceuticals Company | Integrin inhibitor prodrugs |
NZ507222A (en) | 1998-04-09 | 2003-05-30 | Meiji Seika Kaisha | Aminopiperidine derivatives useful as integrin antagonists |
CZ20013155A3 (cs) * | 1999-03-03 | 2002-01-16 | The Procter & Gamble Company | Inhibitory metaloproteas |
AU5379900A (en) * | 1999-06-07 | 2000-12-28 | Shire Biochem Inc. | Thiophene integrin inhibitors |
EP1198231A1 (fr) | 1999-07-21 | 2002-04-24 | American Home Products Corporation | Antagonistes bicycliques selectifs contre l'integrine(alpha)v (beta)3 |
WO2001010844A1 (fr) | 1999-08-05 | 2001-02-15 | Meiji Seika Kaisha, Ltd. | DERIVES D'ACIDE φ-AMINO-α-HYDROXYCARBOXYLIQUE POSSEDANT UN ANTAGONISME αvβ3 D'INTEGRINE |
SK8692002A3 (en) * | 1999-12-28 | 2003-06-03 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
DE10029077A1 (de) * | 2000-06-13 | 2001-12-20 | Bayer Ag | Thiazolylsubstituierte Heterocyclen |
KR100594544B1 (ko) * | 2003-08-27 | 2006-06-30 | 주식회사 엘지생명과학 | 이소옥사졸린 구조를 갖는 캐스파제 저해제 |
GB0412553D0 (en) | 2004-06-04 | 2004-07-07 | Univ Aberdeen | Therapeutic agents for the treatment of bone conditions |
WO2006090234A1 (fr) * | 2005-02-22 | 2006-08-31 | Ranbaxy Laboratories Limited | Derives heterocycliques utilises en tant qu'inhibiteurs d'adherence cellulaire |
GB0705400D0 (en) | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
US9505728B2 (en) | 2012-03-09 | 2016-11-29 | Inception 2, Inc. | Triazolone compounds and uses thereof |
MX2015007433A (es) | 2012-12-20 | 2015-12-07 | Inception 2 Inc | Compuestos de triazolona y usos de los mismos. |
GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
WO2015035059A1 (fr) | 2013-09-06 | 2015-03-12 | Inception 2, Inc. | Composés de triazolone et leurs utilisations |
US9809588B2 (en) | 2014-07-03 | 2017-11-07 | Board Of Regents, The University Of Texas System | GLS1 inhibitors for treating disease |
LT3262028T (lt) | 2014-12-17 | 2022-01-10 | Pimco 2664 Limited | N-(4-hidroksi-4-metil-cikloheksil)-4-fenil-benzensulfonamido ir n-(-4-hidroksi-4-metil-cikloheksil)-4-(2-piridil)-benzensulfonamido junginiai ir jų terapinis panaudojimas |
WO2017004359A1 (fr) | 2015-06-30 | 2017-01-05 | Board Of Regents, University Of Texas System | Inhibiteurs de gls1 pour le traitement de maladies |
CA3009355A1 (fr) | 2015-12-22 | 2017-06-29 | Board Of Regents, The University Of Texas System | Formes de sels et polymorphes de (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridine-2-yl) acetamido)pyridazine-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide |
CA3042693A1 (fr) * | 2016-11-08 | 2018-05-17 | Bristol-Myers Squibb Company | Amides de pyrrole en tant qu'inhibiteurs d'integrine .alpha.v |
RU2020112558A (ru) | 2017-10-18 | 2021-11-18 | Боард Оф Регентс, Зе Юниверсити Оф Тексас Систем | Терапия на основе ингибитора глутаминазы |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62252779A (ja) * | 1986-03-14 | 1987-11-04 | シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド | トランスグルタミナ−ゼ阻害剤 |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
WO1994008577A1 (fr) * | 1992-10-14 | 1994-04-28 | Merck & Co., Inc. | Antagonistes des recepteurs du fibrinogene |
JPH09505590A (ja) * | 1993-11-24 | 1997-06-03 | ザ・デュポン・メルク・ファーマシュウティカル・カンパニー | 新規なイソオキサゾリンおよびイソオキサゾールフィブリノーゲン受容体拮抗剤 |
-
1996
- 1996-05-20 IL IL11832596A patent/IL118325A0/xx unknown
- 1996-05-24 MX MX9708840A patent/MX9708840A/es unknown
- 1996-05-24 CA CA002221980A patent/CA2221980A1/fr not_active Abandoned
- 1996-05-24 WO PCT/US1996/007646 patent/WO1996037492A1/fr not_active Application Discontinuation
- 1996-05-24 EP EP96920476A patent/EP0828737A1/fr not_active Ceased
- 1996-05-24 JP JP8535899A patent/JPH11506436A/ja active Pending
- 1996-05-24 AU AU58762/96A patent/AU5876296A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX9708840A (es) | 1998-03-31 |
WO1996037492A1 (fr) | 1996-11-28 |
JPH11506436A (ja) | 1999-06-08 |
EP0828737A1 (fr) | 1998-03-18 |
AU5876296A (en) | 1996-12-11 |
CA2221980A1 (fr) | 1996-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL118325A0 (en) | Integrin receptor antagonists and pharmaceutical compositions containing them | |
IL99246A0 (en) | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them | |
HUP9901296A3 (en) | Substituted piperidine derivatives as nmda receptor antagonists and pharmaceutical compositions containing them | |
IL103621A0 (en) | Endothelin receptor antagonists and pharmaceutical compositions containing them | |
HUP0100266A3 (en) | 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations | |
AU1345697A (en) | Novel integrin receptor antagonists | |
IL116323A0 (en) | Tachykinin antagonists their preparation and pharmaceutical compositions containing them | |
HUP0201545A2 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them | |
IL125030A0 (en) | Vitronectin receptor antagonists | |
EP1047425A4 (fr) | Antagonistes du recepteur de l'integrine | |
HUP9900754A3 (en) | Vitronectin receptor antagonists | |
ZA962886B (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors their preparation and pharmaceutical compositions containing them | |
IL125034A0 (en) | Vitronectin receptor antagonists | |
IL99539A0 (en) | Fibrinogen receptor antagonists and pharmaceutical compositions containing them | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
EP1007051A4 (fr) | Antagonistes du recepteur de l'integrine | |
IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
HUP0100607A3 (en) | Thrombin receptor antagonists and pharmaceutical compositions containing them | |
EP0880511A4 (fr) | Antagonistes du recepteur integrine | |
IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
NZ329429A (en) | Vitronectin receptor antagonists comprising fibrinogen receptor antagonists and medicaments thereof | |
EP1027337A4 (fr) | Antagonistes des recepteurs d'integrines | |
HUP0002929A3 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same | |
HUP0204113A3 (en) | Novel integrin receptor antagonists, pharmaceutical compositions containing them and their use | |
IL119371A0 (en) | Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them |